Founded in 1999, Dexcom, Inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.
Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1999
Size (employees)
1,900 (est)+57%
Website
dexcom.com
Dexcom was founded in 1999 and is headquartered in San Diego, US

Dexcom Office Locations

Dexcom has an office in San Diego
San Diego, US (HQ)
6340 Sequence Dr

Dexcom Data and Metrics

Dexcom Financial Metrics

Dexcom's revenue was reported to be $573.3 m in FY, 2016 which is a 43% increase from the previous period.
USD

Revenue (FY, 2016)

573.3 m

Revenue growth (FY, 2015 - FY, 2016), %

43%

Gross profit (FY, 2016)

378.4 m

Gross profit margin (FY, 2016), %

66%

Net income (FY, 2016)

(65.6 m)

EBIT (FY, 2016)

(63.9 m)

Market capitalization (27-Jun-2017)

6.5 b

Closing share price (27-Jun-2017)

77.8

Cash (31-Dec-2016)

94.5 m

EV

6.4 b
Dexcom's current market capitalization is $6.5 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

160 m259.2 m402 m573.3 m

Revenue growth, %

62%55%43%

Cost of goods sold

59.9 m82.9 m123.6 m194.9 m

Gross profit

100.1 m176.3 m278.4 m378.4 m

Gross profit Margin, %

63%68%69%66%

Operating expense total

129 m197.8 m335.5 m442.3 m

EBIT

(28.9 m)(21.5 m)(57.1 m)(63.9 m)

EBIT margin, %

(18%)(8%)(14%)(11%)

Interest expense

900 k800 k400 k700 k

Interest income

400 k

Pre tax profit

(29.8 m)(22.3 m)(57.5 m)(64.9 m)

Income tax expense

100 k100 k100 k700 k

Net Income

(29.8 m)(22.4 m)(57.6 m)(65.6 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

43.2 m71.8 m86.1 m94.5 m

Accounts Receivable

26.1 m42.4 m74.1 m101.7 m

Inventories

9 m16 m35.2 m45.4 m

Current Assets

93.1 m145.9 m231.3 m280 m

PP&E

20.7 m31.2 m54.7 m109.4 m

Goodwill

3.2 m3.2 m3.7 m11.3 m

Total Assets

122.5 m184.6 m292 m402.8 m

Total Debt

6.8 m4.6 m2.3 m

Current Liabilities

32.1 m40.6 m66.9 m102.4 m

Additional Paid-in Capital

559.5 m638 m776.8 m905.7 m

Retained Earnings

(475.4 m)(497.8 m)(555.4 m)(621 m)

Total Equity

84.1 m140.2 m221.2 m283.8 m

Debt to Equity Ratio

0.1 x0 x0 x

Debt to Assets Ratio

0.1 x0 x0 x

Financial Leverage

1.5 x1.3 x1.3 x1.4 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(29.8 m)(22.4 m)(57.6 m)(65.6 m)

Depreciation and Amortization

7 m8.4 m10.8 m15 m

Accounts Receivable

(6.5 m)(16 m)(32 m)(27 m)

Inventories

(1.6 m)(7 m)(19 m)(9.8 m)

Cash From Operating Activities

2.4 m23.6 m49 m56.2 m

Purchases of PP&E

(7.9 m)(16.2 m)(33.3 m)(55.7 m)

Cash From Investing Activities

20.9 m(16.8 m)(51.5 m)(55.9 m)

Long-term Borrowings

(200 k)(2.2 m)(2.3 m)(2.3 m)

Cash From Financing Activities

11.8 m21.8 m16.8 m8.1 m

Interest Paid

500 k400 k300 k100 k
Y, 2016

EV/EBIT

-99.8 x

EV/CFO

113.4 x

Financial Leverage

1.4 x

Dexcom Operating Metrics

Dexcom's Facilities was reported to be 2 in FY, 2016
FY, 2016

Patents (US)

334

Patents (foreign)

48

Patents Pending

417

Trademarks (US)

24

Trademarks Foreign

54

Trademarks Pending

38

Facilities

2

Dexcom Market Value History

Dexcom Revenue Breakdown

Dexcom Job Categories

Dexcom Median Salaries

Source: 23 public H-1B filings from Dexcom

Dexcom Online and Social Media Presence

Dexcom News and Updates

Dexcom Company Life and Culture

You may also be interested in